Coronary disease & ACSMeta-analysis

Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis

Eur Heart JPublished

  • Post hoc pooled analysis of randomised trials (RICCADSA, ISAACC, SAVE)
  • subgroup analysis
  • Cox mixed models

Authors' conclusion

Continuous positive airway pressure preferentially improves cardiovascular outcomes in high-risk OSA, while harm in low-risk OSA may counteract this effect.

Study context

Population
Patients with CVD and obstructive sleep apnoea (OSA) in the pooled RICCADSA, ISAACC and SAVE randomised trialspooled RCTs
Participants
3,549 patients
Comparison
Continuous positive airway pressure (CPAP) vs usual care, by high-risk vs low-risk OSA
  • CPAPn = 1,778
  • Usual caren = 1,771reference
Outcome
CPAP effect on MACCE (CV mortality, MI, stroke) within high-risk OSA and the difference vs low-risk status

Pooled result

MACCE: CPAP effect in high-risk vs low-risk OSA

Interaction HR (high-risk vs not high-risk OSA)

.69

95% CI .50-.95

P = 0.024 for interaction

As reported in the abstract

Further pooled results

MACCE, overall

Outcomeinteraction HR (95% CI)
MACCE interaction, without excessive sleepiness (Epworth <11) (subgroup) · Nhigh-risk = 1509.59 (.41-.84)
MACCE interaction, without increased BP (<140/90 mmHg) (subgroup) · Nhigh-risk = 1244.54 (.36-.81)

Original publication

Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis. Eur Heart J. Published 5 August 2025. doi:10.1093/eurheartj/ehaf447

Summarised from the published abstract; every number is checked against it